Literature DB >> 8722379

Pathogenic properties of Helicobacter pylori.

A P Moran1.   

Abstract

Helicobacter pylori possesses factors that allow it to colonize the gastrointestinal mucosa and persist at that site. Here it produces adverse pathological changes, and thereby causes disease. Colonization factors: animal models have shown that motility and the production of urease are essential for colonization by H. pylori. The ability of an organism to adhere to host structures is often considered pivotal in colonization. A number of adhesins associated with H. pylori have been described, which may imply that adherence is a multistep process and that different adhesins mediate adherence to different sites in the gastric tissue. Persistence factors: H. pylori lipopolysaccharide (LPS) possess low immunological activity, thereby minimizing the local inflammatory response and contributing to the persistence of the infection. There is also evidence that the LPS affects the qualitative nature of gastric mucin and stimulates pepsinogen secretion. Whether survival during exposure to antimicrobial agents is aided by the development of coccoid forms with intact membranes and polyphosphate energy reserves is not yet known. Putative disease-inducing factors: these include the vacuolating cytotoxin that is capable of inducing gastric ulceration in mice, ammonia products that induce vacuolation, and phospholipases that may affect the hydrophobicity of the mucosa. Mimicry of Lewis blood group antigens on the surface of H. pylori may also contribute to pathogenesis. Characteristics of certain strains, such as the expression of a cytotoxin-associated gene (cagA) and the ability to induce rapid chemiluminescence in neutrophils, are associated with the induction of peptic ulceration.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8722379

Source DB:  PubMed          Journal:  Scand J Gastroenterol Suppl        ISSN: 0085-5928


  10 in total

1.  Relationship of anti-Lewis x and anti-Lewis y antibodies in serum samples from gastric cancer and chronic gastritis patients to Helicobacter pylori-mediated autoimmunity.

Authors:  M A Heneghan; C F McCarthy; D Janulaityte; A P Moran
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

2.  Relationship of blood group determinants on Helicobacter pylori lipopolysaccharide with host lewis phenotype and inflammatory response.

Authors:  M A Heneghan; C F McCarthy; A P Moran
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

3.  Interleukin-6 (IL-6) and IL-8 are induced in human oral epithelial cells in response to exposure to periodontopathic Eikenella corrodens.

Authors:  H Yumoto; H Nakae; K Fujinaka; S Ebisu; T Matsuo
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

4.  Prevalence of virulent Helicobacter pylori strains in patients affected by idiopathic dysrhythmias.

Authors:  Francesco Franceschi; Donatella Brisinda; Francesco Buccelletti; Maria Pia Ruggieri; Antonio Gasbarrini; Annarita Sorbo; Davide Marsiliani; Angela Venuti; Peter Fenici; Giovanni Gasbarrini; Nicolò Gentiloni Silveri; Riccardo Fenici
Journal:  Intern Emerg Med       Date:  2011-05-12       Impact factor: 3.397

5.  Use of immunoblot assay to define serum antibody patterns associated with Helicobacter pylori infection and with H. pylori-related ulcers.

Authors:  P Aucher; M L Petit; P R Mannant; L Pezennec; P Babin; J L Fauchere
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

6.  Augmented eradication rates of Helicobacter pylori by new combination therapy with lansoprazole, amoxicillin, and rebamipide.

Authors:  K B Hahm; K J Lee; Y S Kim; J H Kim; S W Cho; H Yim; H J Joo
Journal:  Dig Dis Sci       Date:  1998-02       Impact factor: 3.199

7.  Role of adherence in interleukin-8 induction in Helicobacter pylori-associated gastritis.

Authors:  G Rieder; R A Hatz; A P Moran; A Walz; M Stolte; G Enders
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

Review 8.  Metabolism and genetics of Helicobacter pylori: the genome era.

Authors:  A Marais; G L Mendz; S L Hazell; F Mégraud
Journal:  Microbiol Mol Biol Rev       Date:  1999-09       Impact factor: 11.056

9.  Helicobacter pylori outer membrane vesicles modulate proliferation and interleukin-8 production by gastric epithelial cells.

Authors:  Salim Ismail; Mark B Hampton; Jacqueline I Keenan
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

10.  Lack of genetic influence on the innate inflammatory response to helicobacter infection of the gastric mucosa.

Authors:  John G Nedrud; Steven J Czinn; Hua Ding; Brandon M Zagorski; Raymond W Redline; William Twaddell; Thomas G Blanchard
Journal:  Front Immunol       Date:  2012-07-04       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.